Login / Signup
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch!
Vinoth Nadesalingam
Sreedhar Subramanian
Published in:
Alimentary pharmacology & therapeutics (2022)
Keyphrases
</>
ulcerative colitis
patients with inflammatory bowel disease
high dose
low dose